Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers

Breast cancer (BC) prognosis in BRCA1 and BRCA2 mutation carriers has been reported contradictorily, and the significance of variables influencing prognosis in sporadic BC is not established in BC patients with hereditary BRCA1/BRCA2 mutations. In this retrospective cohort study, we analyzed the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Vocka, Michal, Zimovjanova, Martina, Bielcikova, Zuzana, Tesarova, Petra, Petruzelka, Lubos, Mateju, Martin, Krizova, Ludmila, Kotlas, Jaroslav, Soukupova, Jana, Janatova, Marketa, Zemankova, Petra, Kleiblova, Petra, Novotny, Jan, Konopasek, Bohuslav, Chodacka, Martina, Brychta, Milan, Sochor, Marek, Smejkalova-Musilova, Denisa, Cmejlova, Vlastimila, Kozevnikovova, Renata, Miskarova, Lenka, Argalacsova, Sona, Stolarova, Lenka, Lhotova, Klara, Borecka, Marianna, Kleibl, Zdenek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627684/
https://www.ncbi.nlm.nih.gov/pubmed/31141992
http://dx.doi.org/10.3390/cancers11060738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627684/
https://www.ncbi.nlm.nih.gov/pubmed/31141992
http://dx.doi.org/10.3390/cancers11060738

Ejemplares similares